1-3 of 3
Timothy J Martins, PhD
Close
Sort by
Journal Articles

Co-Occurring Mutation Clusters Predict Drug Sensitivity in Acute Myeloid Leukemia

Guangrong Qin, PhD, Shmulevich Ilya, PhD, Taek-Kyun Kim, PhD, Bahar Tercan, PhD, Timothy J Martins, PhD, Jin Dai, PhD, Sylvia Chien, Andrew Carson, PhD, Bradley Patay, MD, Elihu H. Estey, MD, Lawrence A. Loeb, MD PhD, Raymond J. Monnat, MD PhD, Pamela S. Becker, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 12–13.
https://doi.org/10.1182/blood-2020-142727
Published: 2020
Journal Articles

A Precision Medicine Approach Incorporating Both Molecular and In Vitro Functional Data to Treat Patients with Relapsed/Refractory Acute Myeloid Leukemia

Pamela S. Becker, MD PhD, Sylvia Chien, Timothy J Martins, PhD, Andrew Herstein, MD, Cody Hammer, Taylor Sekizaki, Vivian Oehler, MD, C. Anthony Blau, MD, Bradley A Patay, MD, Andrew Carson, PhD, Paul C. Hendrie, MD PhD, Roland B. Walter, MD PhD, Mary-Elizabeth M. Percival, MD MS, Soheil Meschinchi, MD PhD, Katherine Tarlock, MD, Ryan D Cassaday, MD, Kelda Gardner, PA-C, MHS, Heather Smith, PA-C, Andrea M. Perdue, PA-C, Frederick R. Appelbaum, MD, Jerald P. Radich, MD, Elihu H. Estey, MD
Journal: Blood
Blood (2016) 128 (22): 4043.
https://doi.org/10.1182/blood.V128.22.4043.4043
Published: 2016
Journal Articles

Precision Medicine Assays Detect Novel Targetable FLT3 Fusions Amenable to Therapeutic Intervention in a Patient with Refractory Acute Myeloid Leukemia

Bradley A Patay, MD, Andrew Carson, PhD, Timothy J Martins, PhD, Sylvia Chien, Mary-Elizabeth M. Percival, MD MS, Taylor Sekizaki, Cody Hammer, Pamela S. Becker, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5170.
https://doi.org/10.1182/blood.V128.22.5170.5170
Published: 2016